Purple Biotech Ltd. (PPBT)
1.75
+0.10
(+6.06%)
USD |
NASDAQ |
Aug 26, 14:08
Purple Biotech Total Assets (Quarterly) : 14.17M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.17M |
| March 31, 2026 | 14.42M |
| December 31, 2025 | 17.57M |
| September 30, 2025 | 39.06M |
| June 30, 2025 | 34.38M |
| March 31, 2025 | 35.59M |
| December 31, 2024 | 37.04M |
| September 30, 2024 | 35.10M |
| June 30, 2024 | 36.06M |
| March 31, 2024 | 39.86M |
| December 31, 2023 | 44.30M |
| September 30, 2023 | 45.27M |
| June 30, 2023 | 48.00M |
| March 31, 2023 | 53.08M |
| December 31, 2022 | 54.62M |
| September 30, 2022 | 58.54M |
| June 30, 2022 | 61.74M |
| March 31, 2022 | 66.29M |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 10.81M |
| September 30, 2015 | 1.54M |
| June 30, 2015 | 2.009M |
| March 31, 2015 | 2.921M |
| December 31, 2014 | 1.773M |
| September 30, 2014 | 2.784M |
| June 30, 2014 | 1.584M |
| March 31, 2014 | 3.088M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Teva Pharmaceutical Industries Ltd. | 39.86B |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 71.88M |
| Sol-Gel Technologies Ltd. | 53.76M |
| PolyPid Ltd. | 15.23M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.953M |
| Shareholders Equity (Quarterly) | 12.27M |
| Debt to Equity Ratio | 0.0109 |
| Current Ratio | 3.696 |
| Net Debt Paydown Yield | 0.02% |